Placenta, Retained: Clinical Trials

15 trials for Placenta, Retained, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 3 unknown, 1 not yet recruiting. 4 Phase 4, 3 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 44Completed 3, Unknown 1
Not applicable3Completed 2, Unknown 1
Phase 11Completed 1
Phase 21Completed 1

Follow Placenta, Retained: new trials by email Literature Review of Placenta, Retained trials Research Report on Placenta, Retained

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Predictors of Successful Office Operative Hysteroscopy Using a Mini-Resectoscope
Office Operative Hysteroscopy Using the Karl Storz Mini-Resectoscope Without Anesthesia - Retained Products of Conception, Hysteroscopy
Not yet recruitingShaare Zedek Medical Center502026-10-012026-10-15
Timing of Carbetocin Administration in Postpartum Hemorrhage
Carbetocin - Postpartum Hemorrhage, Carbetocin
Not applicableCompletedMehmet Mete Kırlangıç2002025-01-102025-09-18
The Effects of Intrauterine Interventions During Placenta Removal on Pain, Perception of Traumatic Birth, and Early Postpartum Health Indicators in Women
Placenta remove - Placenta, Retained
CompletedKahramanmaras Sutcu Imam University642023-09-152024-11-06
Intrauterine Hyaluronic Acid Gel for Prevention of Intrauterine Adhesions
Intrauterine injection of hyaluronic acid - Prevenetion of Intrauterine Adhesions by Hyaluronic Acid Gel
Not applicableUnknownBarzilai Medical Center1602021-06-252021-07-23
Management of Large Retained Products of Conception (> 4 cm): Need for an Standardized Procedure.
kind of surgery - Placenta, Retained, Placenta; Retention, Fragments, Complicating Puerperium, Without Hemorrhage
CompletedUniversity Hospital, Ghent272020-12-282023-05-11
Secondary Postpartum Hemorrhage
Data collection - Postpartum Hemorrhage, Maternal Morbidity
UnknownUniversity Hospital, Clermont-Ferrand802019-03-012019-02-15
Management of Third-stage of Labor After Second Trimester Medical Pregnancy Termination
Administration of 10 units of intra venous oxytocin after fetal expulsion - Retained Placenta
Phase 4CompletedUniversity Hospital, Bordeaux272016-10-202026-05-12
Effectiveness of Hyaluronic Acid Gel in the Prevention of Intrauterine Adhesions After Second Trimester Abortion
intrauterine self-cross-linked hyaluronic acid gel - Placenta Retained, Uterine Diseases
Phase 4UnknownIstanbul University602016-09-012016-08-16
The Correlation Between Clinical Diagnosis of Retained Placenta And Histology
no interventions - Retained Product of Pregnancy
CompletedBait Balev Hospital2402016-09-012020-02-05
Two Different Regimens of Misoprostol in Retained Placenta
Misoprostol - Postpartum Haemorrhage, Retained Placenta
Phase 2CompletedHawler Medical University5092016-03-012019-02-22
GOT-IT Trial: Glyceryl Trinitrate for Retained Placenta
Glyceryl Trinitrate, Matched Placebo - Placenta, Retained
Phase 4CompletedUniversity of Edinburgh11072014-09-012018-05-21
Assessing Childbirth-related Complications at the Community Level in Kenya
Puerperal Sepsis, Postpartum Hemorrhage
CompletedWilson Liambila5852012-08-012014-04-28
Intraumbilical Misoprostol in Retained Placenta
Misoprostol, Normal saline - Retained Placenta
Phase 1CompletedHawler Medical University462011-04-012013-11-05
Intravenous Nitroglycerin for Retained Placenta Extraction: a Multicenter Study
nitroglycerine, NSS - Retained Placenta
Phase 4CompletedMahidol University1002008-02-012011-03-08
Optimisation of the Management of Placental Delivery in Second Trimester Pregnancy Interruption
Misoprostol, Oxytocin - Placenta, Retained, Postpartum Hemorrhage
Not applicableCompletedThe University of Western Australia2512005-02-012009-07-09

Narrower conditions

Postpartum Hemorrhage (5)  ·  Hemorrhage (2)  ·  Abortion, Incomplete (1)  ·  Eclampsia (1)  ·  Gynatresia (1)  ·  Pre-Eclampsia (1)  ·  Puerperal Infection (1)  ·  Uterine Diseases (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (15)  ·  Placenta Diseases (15)  ·  Pregnancy Complications (15)  ·  Urogenital Diseases (15)  ·  Obstetric Labor Complications (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Puerperal Disorders (5)  ·  Uterine Hemorrhage (5)  ·  Hemorrhage (3)  ·  Female Urogenital Diseases (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Abortion, Spontaneous (1)  ·  Hypertension, Pregnancy-Induced (1)

Interventions

Misoprostol (3)  ·  Nitroglycerin (2)  ·  Saline Solution (2)  ·  Anesthesia (1)  ·  Data Collection (1)  ·  Hysteroscopy (1)  ·  Oxytocin (1)  ·  carbetocin (1)

Sponsors

Hawler Medical University (2)  ·  Bait Balev Hospital (1)  ·  Barzilai Medical Center (1)  ·  Istanbul University (1)  ·  Kahramanmaras Sutcu Imam University (1)  ·  Mahidol University (1)  ·  Mehmet Mete Kırlangıç (1)  ·  Shaare Zedek Medical Center (1)  ·  The University of Western Australia (1)  ·  University Hospital, Bordeaux (1)  ·  University Hospital, Clermont-Ferrand (1)  ·  University Hospital, Ghent (1)  ·  University of Edinburgh (1)  ·  Wilson Liambila (1)

Countries

France (2)  ·  Iraq (2)  ·  Israel (2)  ·  Turkey (Türkiye) (2)  ·  Australia (1)  ·  Belgium (1)  ·  Kenya (1)  ·  Thailand (1)  ·  United Kingdom (1)

Top investigators

Ariana Kh. Jawad, Assistant professor (1)  ·  Bahar Q. Muhammad, CABOG (1)  ·  Fiona C Denison, Dr (1)  ·  Jan E. Dickinson, MD (1)  ·  Jinan N. Hassan, IBMS (1)  ·  Khalida M. Ameen, CABOG (1)  ·  Khansa H. Abdul Rahman, MBChB (1)  ·  Maryam B. Mahmood, FICOG (1)  ·  Namir G. Al Tawil, Professor (1)  ·  Ozlem Dural, M.D. (1)  ·  Salim A. Salim, Master (1)  ·  Shahla K. Alalaf, Clinical M.D (1)  ·  Shahla K. Alalaf, professor (1)  ·  Sheelan S Rajab, High Diploma (1)

Results publications

PMID 10137741, PMID 15105384, PMID 18794220, PMID 19024419, PMID 19431006, PMID 20302625, PMID 20359341, PMID 2190942, PMID 24082042, PMID 31887169, PMID 33705565, PMID 8875731, PMID 8909956

NIH funding

2016 (1)